Risk Factors for Persistence or Recurrence of High-Grade Cervical Squamous Intraepithelial Lesions.


Journal

Revista do Colegio Brasileiro de Cirurgioes
ISSN: 1809-4546
Titre abrégé: Rev Col Bras Cir
Pays: Brazil
ID NLM: 7809515

Informations de publication

Date de publication:
2023
Historique:
received: 06 02 2023
accepted: 08 09 2023
medline: 11 12 2023
pubmed: 6 12 2023
entrez: 6 12 2023
Statut: epublish

Résumé

to evaluate whether the colposcopic lesion size , age, kind of surgery, the status of the surgical margins and the expression of the p16 and Ki-67 immunomarkers are risk factors for persistence or recurrence of the lesion. a cross-sectional, observational, retrospective study of patients submitted to cold knife conization (CKC) or the loop electrosurgical excision procedure for cervical intraepithelial neoplasia 2 or 3. The colposcopic lesion size, age, surgical method, involvement of the surgical margins, and p16/Ki-67 immunomarker expression were analyzed in relation to lesion persistence and recurrence. seventy-one women were treated with cold knife conization and 200 were treated with loop electrosurgical excision. Of these, 95 had cervical intraepithelial neoplasia 2, 173 had cervical intraepithelial neoplasia 3, 183 had free surgical margins, 76 had compromised margins, and 12 showed damage by processing artifact or fragments. Among the 76 cases with positive margins, 55, 11, and 10 showed endocervical margin involvement, ectocervical margin involvement, and both endocervial and ectocervical margin involvement, respectively. Of the 264 followed-up patients, 38 had persistent or recurrent disease. A multiple logistic regression indicated that positive endocervical margins are the only independent risk factor for the persistence/recurrence of cervical intraepithelial neoplasia. No significant association was identified between the colposcopic lesion size, age, surgery type, or p16/Ki-67 immunomarker expression and lesion persistence or recurrence.

Identifiants

pubmed: 38055549
pii: S0100-69912023000100241
doi: 10.1590/0100-6991e-20233537-en
pmc: PMC10673582
pii:
doi:

Substances chimiques

Ki-67 Antigen 0

Types de publication

Journal Article

Langues

eng por

Sous-ensembles de citation

IM

Pagination

e20233537

Références

Sao Paulo Med J. 2012;130(2):92-6
pubmed: 22481754
Malays J Pathol. 2017 Dec;39(3):257-265
pubmed: 29279588
Rev Col Bras Cir. 2016 Feb;43(1):35-41
pubmed: 27096855
J Gynecol Oncol. 2016 Sep;27(5):e54
pubmed: 27401478
Br J Obstet Gynaecol. 1989 Sep;96(9):1061-6
pubmed: 2804008
J Low Genit Tract Dis. 2009 Jan;13(1):10-2
pubmed: 19098600
BMC Cancer. 2015 Oct 20;15:744
pubmed: 26486312
J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):188-92
pubmed: 24662299
Int J Gynecol Pathol. 2020 Jul;39(4):384-390
pubmed: 32515923
Int J Gynaecol Obstet. 2009 Nov;107(2):107-10
pubmed: 19628208
Onco Targets Ther. 2016 Jun 29;9:3907-15
pubmed: 27418835
Eur J Obstet Gynecol Reprod Biol. 2012 Nov;165(1):86-90
pubmed: 22771223
Lancet Oncol. 2017 Dec;18(12):1665-1679
pubmed: 29126708
Lancet Oncol. 2007 Nov;8(11):985-93
pubmed: 17928267
Diagn Cytopathol. 2010 Aug;38(8):618-23
pubmed: 19941372
Eur J Surg Oncol. 2010 Nov;36(11):1073-9
pubmed: 20870375
Rev Bras Ginecol Obstet. 2017 Jun;39(6):288-293
pubmed: 28231598
Am J Obstet Gynecol. 2005 May;192(5):1379-81
pubmed: 15902114
J Low Genit Tract Dis. 2010 Jan;14(1):49-55
pubmed: 20040836
Gynecol Oncol. 1995 Aug;58(2):206-9
pubmed: 7622107
J Low Genit Tract Dis. 2014 Oct;18(4):286-90
pubmed: 24633169
Medicine (Baltimore). 2018 Jan;97(4):e9719
pubmed: 29369205
Int J Gynaecol Obstet. 2009 Apr;105(1):14-7
pubmed: 19111301
Obstet Gynecol. 1997 Mar;89(3):419-22
pubmed: 9052597
Eur J Gynaecol Oncol. 2004;25(5):587-90
pubmed: 15493171
J Low Genit Tract Dis. 2017 Apr;21(2):129-136
pubmed: 27977541
Gynecol Oncol. 2003 Sep;90(3):587-92
pubmed: 13678729
Am J Clin Pathol. 2009 Sep;132(3):378-90
pubmed: 19687314
Obstet Gynecol. 1998 Oct;92(4 Pt 2):727-35
pubmed: 9764690

Auteurs

Dulcimary Dias Bittencourt (DD)

- Universidade Federal do Paraná, Tocoginecologia - Curitiba - PR - Brasil.

Rita Maira Zanine (RM)

- Universidade Federal do Paraná, Tocoginecologia - Curitiba - PR - Brasil.

Ana Paula Martins Sebastião (APM)

- Universidade Federal do Paraná, Patologia - Curitiba - PR - Brasil.

Carmen Marcondes Ribas (CM)

- Faculdade Evangélica Mackenzie do Paraná - Curitiba - PR - Brasil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH